LearnGlossaryMarketStocksSuperinvestorsSign in

SOLV

Solventum Corporation

Healthcare · $15.5B market cap

Verdict

We can't put a fair value on SOLV right now.

Business quality

1 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth—?
Equity per share growth—?
Sales growth0.8% a year✗
Free cash flow growth-13.8% a year✗
Return on invested capital11.9%✓

Follow SOLV

Track it on your watchlist and see the full analysis. Free.

Create a free account

Superinvestors

3 of the investors we track hold SOLV. Who we track

Nelson Peltz

Trian Fund Management · as of Q2 2026

$635.5M

8,236,753 shares

Richard Pzena

Pzena Investment Management · as of Q2 2026

$32.2M

417,770 shares

Mairs & Power Funds

Mairs & Power Funds · as of Q2 2026

$5.6M

72,441 shares

Insider activity

Since Sep 1, 2026: no open-market purchases and 2 other filings (stock awards, tax withholding and similar). Why purchases matter

Other filings

Hanson Bryan C

Chief Executive Officer · 2026-09-01

Tax withholding

$2.4M

Hanson Bryan C

Chief Executive Officer · 2026-09-01

Option exercise

67,261 shares

About Solventum Corporation

Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated…

Medical - Instruments & Supplies

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works